EP 1045920 A1 20001025 - NUCLEOTIDE EXPRESSION SYSTEMS WITH REDUCED IMMUNOGENICITY FOR USE IN GENE THERAPY
Title (en)
NUCLEOTIDE EXPRESSION SYSTEMS WITH REDUCED IMMUNOGENICITY FOR USE IN GENE THERAPY
Title (de)
NUKLEOTIDEXPRESSION-SYSTEME MIT VERMINDERTER IMMUNOGENITÄT ZUR VERWENDUNG IN GENTHERAPIE
Title (fr)
SYSTEMES D'EXPRESSION NUCLEOTIDIQUES A IMMUNOGENICITE REDUITE DESTINES A LA THERAPIE GENIQUE
Publication
Application
Priority
- US 9900733 W 19990113
- US 7140998 P 19980114
Abstract (en)
[origin: WO9936562A1] This invention suppresses the immune response to viral or non-viral based methods of gene delivery by incorporating immunosuppressive genes within the gene delivery system. These immunosuppressive genes may be used in addition to a therapeutic treatment or as a therapeutic treatment by themselves.
IPC 1-7
IPC 8 full level
A61K 31/711 (2006.01); A61K 35/76 (2006.01); A61K 38/16 (2006.01); A61K 48/00 (2006.01); A61P 37/06 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/34 (2006.01); C12R 1/93 (2006.01)
CPC (source: EP)
A61K 38/162 (2013.01); A61K 48/00 (2013.01); A61P 37/06 (2017.12)
Citation (search report)
See references of WO 9936562A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9936562 A1 19990722; WO 9936562 A9 19990930; AU 2114899 A 19990802; CA 2318664 A1 19990722; EP 1045920 A1 20001025; JP 2002508976 A 20020326
DOCDB simple family (application)
US 9900733 W 19990113; AU 2114899 A 19990113; CA 2318664 A 19990113; EP 99901457 A 19990113; JP 2000540263 A 19990113